• 29. September 2022

Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide)

Bypresseportal.de

Mai 30, 2016
Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide)
Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide)

Teva [Newsroom]
Amsterdam (ots/PRNewswire) – Positive conclusion of a European DCP for approval of a tiotropium bromide-based maintenance treatment for those people living with COPD in a new inhaler (Zonda®) Teva Pharmaceutical Industries Ltd., announced today that … Lesen Sie hier weiter…

Teile den Beitrag mit Freunden
Booking.com